Skip to the comparison

Medicare GLP-1 Bridge sets a $50 copay from 1 July 2026

Event date 1 Jul 2026 source CMS

We track prices, terms and availability. We are not clinicians, this page is not medically reviewed, and nothing here is medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.

What changed

CMS opened the Medicare GLP-1 Bridge demonstration on 1 July 2026, fixing the beneficiary copay at $50 a month for covered GLP-1 prescriptions through 31 December 2027.

Source: CMS (opens in a new tab)

What it means

For a beneficiary who qualifies, this is the lowest figure on our Wegovy cost page. It also has an end date: the program runs to 31 December 2027. CMS names BALANCE in Part D only as a potential next step, so what follows is not yet settled.

Who qualifies, which drugs are covered and how approval works are on our Medicare GLP-1 Bridge pages, each rule cited to the CMS document it comes from. The cash prices the $50 compares with are on our Wegovy cost guide.

How this site works

How we rate providers

Ratings weigh verified price, total first-year cost, state availability, speed to prescription, cancellation terms and regulatory record. Full scoring rubric.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records, never a provider's marketing claims.

How we make money

When you sign up with a provider through our links, we may earn a referral fee. Fees never influence a rating, a price, or a position in a table. Full advertiser disclosure.